The Lancet. Respiratory medicine
Plasma interleukin-6 concentrations, metabolic dysfunction, and asthma severity: a cross-sectional analysis of two cohorts.
Acetylcysteine in IPF: the knockout blow?
ARDS in 2015: new clinical directions, new biological insights.
Idiopathic pulmonary fibrosis: continuing to make progress.
Classification of usual interstitial pneumonia in patients with interstitial lung disease: assessment of a machine learning approach using high-dimensional transcriptional data.
Association of hospital admission and forced vital capacity endpoints with survival in patients with idiopathic pulmonary fibrosis: analysis of a pooled cohort from three clinical trials.
Mesenchymal stem (stromal) cells for treatment of acute respiratory distress syndrome - authors' reply.
Mesenchymal stem (stromal) cells for treatment of ARDS: a phase 1 clinical trial.
Mesenchymal stem cells: mechanisms of potential therapeutic benefit in ARDS and sepsis.
Effect of telomere length on survival in patients with idiopathic pulmonary fibrosis: an observational cohort study with independent validation.
